Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Gemphire Therapeutics Inc (GEMP)

Gemphire Therapeutics Inc (GEMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,462
  • Shares Outstanding, K 14,872
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,640 K
  • 60-Month Beta 2.83
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade GEMP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.73
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 01/02/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.24 +26.05%
on 12/06/19
0.39 -22.46%
on 12/03/19
-0.06 (-16.43%)
since 11/29/19
3-Month
0.24 +26.05%
on 12/06/19
0.44 -31.82%
on 10/22/19
-0.08 (-21.42%)
since 09/30/19
52-Week
0.24 +26.05%
on 12/06/19
1.49 -79.80%
on 03/06/19
-0.47 (-61.04%)
since 12/28/18

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Gemphire Therapeutics Inc. is a biopharmaceutical company. It focused on developing and commercializing therapies for the treatment of dyslipidemia. The company's product candidate is gemcabene (CI-1027), an oral therapy for patients who are unable to achieve normal levels of LDL-C or triglycerides with...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.36
1st Resistance Point 0.33
Last Price 7.50
1st Support Level 0.28
2nd Support Level 0.26
3rd Support Level N/A

See More

Last Price 7.50
52-Week High 1.49
Fibonacci 61.8% 1.01
Fibonacci 50% 0.86
Fibonacci 38.2% 0.71
52-Week Low 0.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar